Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Net Cash Flow (2016 - 2025)

Traws Pharma's Net Cash Flow history spans 14 years, with the latest figure at -$2.6 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$2.6 million for Q4 2025, down 116.31% from a year ago — trailing twelve months through Dec 2025 was -$15.0 million (down 52.63% YoY), and the annual figure for FY2025 was -$17.6 million, down 3377.24%.
  • Net Cash Flow for Q4 2025 was -$2.6 million at Traws Pharma, up from -$4.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $29.0 million in Q1 2021 to a low of -$11.5 million in Q3 2024.
  • The 5-year median for Net Cash Flow is -$4.3 million (2021), against an average of -$1.1 million.
  • The sharpest move saw Net Cash Flow soared 614.84% in 2021, then plummeted 156.79% in 2024.
  • Year by year, Net Cash Flow stood at -$4.3 million in 2021, then rose by 9.67% to -$3.9 million in 2022, then dropped by 14.06% to -$4.4 million in 2023, then soared by 459.75% to $15.9 million in 2024, then tumbled by 116.31% to -$2.6 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$2.6 million, -$4.1 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.